Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation

Rai Muhammad Sarfraz,1 Mahmood Ahmad,2 Asif Mahmood,3 Muhammad Rouf Akram,1 Asad Abrar2 1Faculty of Pharmacy, University of Sargodha, Sargodha, 2Faculty of Pharmacy and Alternative Medicines, The Islamia University of Bahawalpur, Bahawalpur, 3Institute of Pharmacy, Physiology and Pharmacology, Univ...

Full description

Bibliographic Details
Main Authors: Sarfraz RM, Ahmad M, Mahmood A, Akram MR, Abrar A
Format: Article
Language:English
Published: Dove Medical Press 2017-10-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/development-of-beta-cyclodextrin-based-hydrogel-microparticles-for-sol-peer-reviewed-article-DDDT
_version_ 1818909431885201408
author Sarfraz RM
Ahmad M
Mahmood A
Akram MR
Abrar A
author_facet Sarfraz RM
Ahmad M
Mahmood A
Akram MR
Abrar A
author_sort Sarfraz RM
collection DOAJ
description Rai Muhammad Sarfraz,1 Mahmood Ahmad,2 Asif Mahmood,3 Muhammad Rouf Akram,1 Asad Abrar2 1Faculty of Pharmacy, University of Sargodha, Sargodha, 2Faculty of Pharmacy and Alternative Medicines, The Islamia University of Bahawalpur, Bahawalpur, 3Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Faisalabad, Pakistan Abstract: The aim of this study was to enhance the solubility of rosuvastatin (RST) calcium by developing β-cyclodextrin-g-poly(2-acrylamido-2-methylpropane sulfonic acid [AMPS]) hydrogel microparticles through aqueous free-radical polymerization technique. Prepared hydrogel microparticles were characterized for percent entrapment efficiency, solubility studies, Fourier transform infrared spectroscopy, differential scanning calorimetry, thermal gravimetric analysis, powder X-ray diffraction, scanning electron microscopy, zeta size and potential, swelling and release studies. Formulations (HS1–HS9) have shown entrapment efficiency between 83.50%±0.30% and 88.50%±0.25%, and optimum release was offered by formulation HS7 at both pH levels, ie, 1.2 (89%) and 7.4 (92%). The majority of microparticles had a particle size of less than 500 µm and zeta potential of –37 mV. Similarly, optimum solubility, ie, 10.66-fold, was determined at pH 6.8 as compared to pure RST calcium, ie, 7.30-fold. In vivo studies on fabricated hydrogel microparticulate system in comparison to pure drug were carried out, and better results regarding pharmacokinetic parameters were seen in the case of hydrogel microparticles. A potential approach for solubility enhancement of RST calcium and other hydrophobic moieties was successfully developed. Keywords: hydrogel microparticles, rosuvastatin calcium, polymerization, β-cyclodextrin solubility
first_indexed 2024-12-19T22:26:49Z
format Article
id doaj.art-eb6372c821254152aaa7ce0cb02510d6
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-12-19T22:26:49Z
publishDate 2017-10-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-eb6372c821254152aaa7ce0cb02510d62022-12-21T20:03:30ZengDove Medical PressDrug Design, Development and Therapy1177-88812017-10-01Volume 113083309635292Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluationSarfraz RMAhmad MMahmood AAkram MRAbrar ARai Muhammad Sarfraz,1 Mahmood Ahmad,2 Asif Mahmood,3 Muhammad Rouf Akram,1 Asad Abrar2 1Faculty of Pharmacy, University of Sargodha, Sargodha, 2Faculty of Pharmacy and Alternative Medicines, The Islamia University of Bahawalpur, Bahawalpur, 3Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Faisalabad, Pakistan Abstract: The aim of this study was to enhance the solubility of rosuvastatin (RST) calcium by developing β-cyclodextrin-g-poly(2-acrylamido-2-methylpropane sulfonic acid [AMPS]) hydrogel microparticles through aqueous free-radical polymerization technique. Prepared hydrogel microparticles were characterized for percent entrapment efficiency, solubility studies, Fourier transform infrared spectroscopy, differential scanning calorimetry, thermal gravimetric analysis, powder X-ray diffraction, scanning electron microscopy, zeta size and potential, swelling and release studies. Formulations (HS1–HS9) have shown entrapment efficiency between 83.50%±0.30% and 88.50%±0.25%, and optimum release was offered by formulation HS7 at both pH levels, ie, 1.2 (89%) and 7.4 (92%). The majority of microparticles had a particle size of less than 500 µm and zeta potential of –37 mV. Similarly, optimum solubility, ie, 10.66-fold, was determined at pH 6.8 as compared to pure RST calcium, ie, 7.30-fold. In vivo studies on fabricated hydrogel microparticulate system in comparison to pure drug were carried out, and better results regarding pharmacokinetic parameters were seen in the case of hydrogel microparticles. A potential approach for solubility enhancement of RST calcium and other hydrophobic moieties was successfully developed. Keywords: hydrogel microparticles, rosuvastatin calcium, polymerization, β-cyclodextrin solubilityhttps://www.dovepress.com/development-of-beta-cyclodextrin-based-hydrogel-microparticles-for-sol-peer-reviewed-article-DDDTHydrogel microparticlesrosuvastatin calciumpolymerizationβ-cyclodextrin solubility
spellingShingle Sarfraz RM
Ahmad M
Mahmood A
Akram MR
Abrar A
Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation
Drug Design, Development and Therapy
Hydrogel microparticles
rosuvastatin calcium
polymerization
β-cyclodextrin solubility
title Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation
title_full Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation
title_fullStr Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation
title_full_unstemmed Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation
title_short Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation
title_sort development of beta cyclodextrin based hydrogel microparticles for solubility enhancement of rosuvastatin an in vitro and in vivo evaluation
topic Hydrogel microparticles
rosuvastatin calcium
polymerization
β-cyclodextrin solubility
url https://www.dovepress.com/development-of-beta-cyclodextrin-based-hydrogel-microparticles-for-sol-peer-reviewed-article-DDDT
work_keys_str_mv AT sarfrazrm developmentofbetacyclodextrinbasedhydrogelmicroparticlesforsolubilityenhancementofrosuvastatinaninvitroandinvivoevaluation
AT ahmadm developmentofbetacyclodextrinbasedhydrogelmicroparticlesforsolubilityenhancementofrosuvastatinaninvitroandinvivoevaluation
AT mahmooda developmentofbetacyclodextrinbasedhydrogelmicroparticlesforsolubilityenhancementofrosuvastatinaninvitroandinvivoevaluation
AT akrammr developmentofbetacyclodextrinbasedhydrogelmicroparticlesforsolubilityenhancementofrosuvastatinaninvitroandinvivoevaluation
AT abrara developmentofbetacyclodextrinbasedhydrogelmicroparticlesforsolubilityenhancementofrosuvastatinaninvitroandinvivoevaluation